AF488-conjugated CD19 Antibody (4G7)

(Synonyms: CD19,CD19-AF488,4G7)

AF488-conjugated CD19 Antibody (4G7) is a Mouse-derived and AF488 conjugated monoclonal antibody, targeting to CD19.

For research use only. We do not sell to patients.
  • Host:

    Mouse

  • Isotype:

    Mouse IgG1,κ

  • Application:

    FC

  • Reactivity :

    Human

  • Formulation:

    Supplied in PBS (pH 7.2) containing 0.1% Proclin300 and protein stabilizer.

  • Conjugation:
    AF488

Applications

Application
FC Info
FC: Flow Cytometry
Dilution Ratio 5 ul per 106 cells in a 100 µl suspension

Product Details

Description

AF488-conjugated CD19 Antibody (4G7) is a Mouse-derived and AF488 conjugated monoclonal antibody, targeting to CD19.

  • Host Mouse
  • Clonality Monoclonal
  • Species Reactivity
    Human
Conjugation

AF488

Modification

Unmodified

Isotype

Mouse IgG1,κ

Product Properties

  • Appearance

    Solution

  • Formulation

    Supplied in PBS (pH 7.2) containing 0.1% Proclin300 and protein stabilizer.

  • Storage & Stability

    Stored at 2-8°C for 1 year, protect from light, do not freeze.

  • Shipping

    Shipping with blue ice.

Background

  • Function

    CD19 is a B cell-specific transmembrane glycoprotein and a core member of the B cell receptor (BCR) co-receptor complex. It can significantly enhance BCR signaling by activating signaling pathways such as PI3K and BTK, promoting B cell development, activation, and antibody production. CD19 is present throughout almost the entire B cell development process and is a biomarker for all B cells. CD19 is an important marker for immunophenotyping of B-cell leukemia and lymphoma, and is also one of the targets for CAR-T cell therapy, bispecific antibodies, and other B cell-targeted therapies.

  • Expression


    Tissue_specificity:Detected in B cells in the marginal zone of lymph nodes and germinal centers (PubMed:2463100) . Detected in blood B cells (protein levels) (PubMed:16672701, PubMed:2463100) .

  • Isoforms & Post-Translational Modification

    CD19 has 2 isomers: P15391-1: 61128 Da (predicted); P15391-2: 61200 Da (predicted).
    Phosphorylated on tyrosine following B-cell activation. Phosphorylated on tyrosine residues by LYN. Tyrosine residues are phosphorylated sequentially after activation of the B cell receptor. Phosphorylation of Tyr-531 is extremely rapid, followed by phosphorylation at Tyr-409.

  • Subunit

    Interacts with CR2/CD21. Part of a complex composed of CD19, CR2/CD21, CD81 and IFITM1/CD225 in the membrane of mature B-cells. Interacts directly with CD81 (via the second extracellular domain); this interaction is initiated early during biosynthesis in the ER/pre-Golgi compartments and is essential for trafficking and compartmentalization of CD19 receptor on the cell surface of activated B cells. Interacts with VAV. Interacts with GRB2 and SOS when phosphorylated on Tyr-348 and/or Tyr-378. Interacts with PLCG2 when phosphorylated on Tyr-409. Interacts with LYN. Interacts (when tyrosine phosphorylated) with the regulatory p85 subunit of phosphatidylinositol 3-kinase (PIK3R1 or PIK3R2). Interacts with GRB2

  • Synonyms

    CD19,CD19-AF488,4G7

AF488-conjugated CD19 Antibody (4G7) Related Classifications

MOQ
Minimum order quantity
100 mg

Get Quote In-stock

Other size
Get Quote
Please select quantity
Amount: USD 0.00